Galectin Therapeutics Inc. (OTC: PRWP) today announced the appointment of two new members to the Board of Directors: Kevin D. Freeman, CFA, and John Mauldin. The two new Directors will provide significant business acumen to Galectin Therapeutics. With the additions, Galectin Therapeutics’ Board of Directors is comprised of 11 members.
